U.S. pharma huge copyright scrapped two experimental weight loss products very last calendar year—a as soon as-day by day pill, lotiglipron, as a result of elevated liver enzymes and a two times-daily pill, danuglipron, as a result of powerful Unwanted side effects—but CEO Albert Bourla has reported the company is set to “Enjoy and gain” wi